Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.550
+0.010 (0.65%)
At close: May 9, 2025, 4:00 PM
1.550
0.00 (0.00%)
After-hours: May 9, 2025, 4:05 PM EDT
Q32 Bio Stock Forecast
QTTB's stock price has decreased by -94.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 24, with a low estimate of 3.00 and a high estimate of 95. The average target predicts an increase of 1,448.39% from the current stock price of 1.55.
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for Q32 Bio stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 5 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +867.74% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | +93.55% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | +158.06% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +1,319.35% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.28
from -6.58
EPS Next Year
-4.31
from -4.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -4.14 | -2.40 | -3.33 |
| Avg | -4.28 | -4.31 | -5.50 |
| Low | -4.25 | -5.17 | -7.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.